Literature DB >> 2139267

Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19.

K K Conzelmann1, J H Cox, L G Schneider, H J Thiel.   

Abstract

Complementary DNA spanning the entire genome of the attenuated rabies virus strain SAD B19 which is used for oral immunization of foxes in Europe was cloned and sequenced. The viral genome comprises 11,928 nucleotides and encodes the five viral proteins N, NS, M, G, and L. Deduced protein sequences are highly similar to those of the pathogenic PV strain, homologies ranging from 90.6% for the M to 98.6% for the L protein. The five cistrons are separated by intergenic regions of 2, 5, 5, and 24 nucleotides, respectively. The G transcription stop/polyadenylation consensus signal in SAD B19 is destroyed by a deletion of three A residues. The strong conservation of both noncoding and coding nucleotide sequences indicates a high selective pressure on the primary structure of rabies virus genomic RNA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139267     DOI: 10.1016/0042-6822(90)90433-r

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  130 in total

1.  A panel of monoclonal antibodies targeting the rabies virus phosphoprotein identifies a highly variable epitope of value for sensitive strain discrimination.

Authors:  S A Nadin-Davis; M Sheen; M Abdel-Malik; L Elmgren; J Armstrong; A I Wandeler
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Rescue of rabies virus from cloned cDNA and identification of the pathogenicity-related gene: glycoprotein gene is associated with virulence for adult mice.

Authors:  N Ito; M Takayama; K Yamada; M Sugiyama; N Minamoto
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Regular exposure to rabies virus and lack of symptomatic disease in Serengeti spotted hyenas.

Authors:  M L East; H Hofer; J H Cox; U Wulle; H Wiik; C Pitra
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

4.  Molecular basis of neurovirulence of flury rabies virus vaccine strains: importance of the polymerase and the glycoprotein R333Q mutation.

Authors:  Lihong Tao; Jinying Ge; Xijun Wang; Hongyue Zhai; Tao Hua; Bolin Zhao; Dongni Kong; Chinglai Yang; Hualan Chen; Zhigao Bu
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

5.  Highly stable expression of a foreign gene from rabies virus vectors.

Authors:  T Mebatsion; M J Schnell; J H Cox; S Finke; K K Conzelmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

6.  Recombinant rabies virus expressing IL-15 enhances immunogenicity through promoting the activation of dendritic cells in mice.

Authors:  Tiange Chen; Yajing Zhang; Zhao Wang; Jie Yang; Mingming Li; Kunlun Wang; Min Cui; Zhen F Fu; Ling Zhao; Ming Zhou
Journal:  Virol Sin       Date:  2017-08-29       Impact factor: 4.327

7.  Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome.

Authors:  James P McGettigan; Kristin Naper; Jan Orenstein; Martin Koser; Philip M McKenna; Matthias J Schnell
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccine.

Authors:  Amy B Papaneri; John G Bernbaum; Joseph E Blaney; Peter B Jahrling; Matthias J Schnell; Reed F Johnson
Journal:  Virus Res       Date:  2014-12-04       Impact factor: 3.303

9.  PPEY motif within the rabies virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity.

Authors:  Christoph Wirblich; Gene S Tan; Amy Papaneri; Peter J Godlewski; Jan Marc Orenstein; Ronald N Harty; Matthias J Schnell
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

10.  Expression of the nucleoprotein of rabies virus in Escherichia coli and mapping of antigenic sites.

Authors:  H Goto; N Minamoto; H Ito; T R Luo; M Sugiyama; T Kinjo; A Kawai
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.